Kalkinemedia

Published September 16, 2026

Optimi Health to Launch Health Canada-Approved Phase 3 MDMA Therapy Trial for PTSD ...

Read the full story at Kalkinemedia

(CSE: OPTI) has revealed plans to commence a Health Canada-authorized Phase 3 clinical trial assessing MDMA -assisted therapy for post-traumatic stress.